tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Amgen price target raised to $326 from $315 at UBS

UBS analyst Trung Huynh raised the firm’s price target on Amgen (AMGN) to $326 from $315 and keeps a Neutral rating on the shares. UBS forecasts a small beat for Amgen in Q2 results following two solid quarter of beats in the row, the analyst tells investors in a research note. The firm continues to believe the rare disease products could be bumpy.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1